Analysis

FS KKR Capital Corp. has announced a reduction to its shareholder distribution, a move prompted by mounting pressure within its...

Despite securing two significant regulatory approvals from the U.S. Food and Drug Administration (FDA) in early March 2026, shares of...

Axsome Therapeutics is making a bold and resource-intensive move to significantly expand its commercial operations. The biopharmaceutical company has announced...

Kyndryl Holdings Inc. is navigating a severe crisis of confidence, marked by a steep decline in its share price and...

In a bold maneuver within the challenging U.S. housing market, Opendoor Technologies is reviving its mortgage lending operations. The iBuyer...

In a significant breakthrough for its public sector ambitions, Workday has announced a major contract win with the U.S. Department...

The clinical-stage biotech firm Replimune is advancing its lead therapeutic candidate with a clear emphasis on navigating regulatory requirements. The...

Investor focus is sharpening on BitMine as the digital asset holding company transitions from a strategy of pure accumulation to...

Adobe enters a pivotal week, with its quarterly results scheduled for March 12. Investors are keenly watching to see if...

The equity of German biotechnology firm BioNTech is navigating a period of significant volatility. As the company accelerates its strategic...